Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening
Authors:
- 7 July 2011
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 108 (30) , 12307-12312
Abstract
The question of how dispersed mutations in one protein engender the same gain-of-function phenotype is of great interest. Here we focus on mutations in glycyl-tRNA synthetase (GlyRS) that cause an axonal form of Charcot–Marie–Tooth (CMT) diseases, the most common hereditary peripheral neuropathies. Because the disease phenotype is dominant, and not correlated with defects in the role of GlyRS in protein synthesis, the mutant proteins are considered to be neomorphs that gain new functions from altered protein structure. Given that previous crystal structures showed little conformational difference between dimeric wild-type and CMT-causing mutant GlyRSs, the mutant proteins were investigated in solution by hydrogen-deuterium exchange (monitored by mass spectrometry) and small-angle X-ray scattering to uncover structural changes that could be suppressed by crystal packing interactions. Significantly, each of five spatially dispersed mutations induced the same conformational opening of a consensus area that is mostly buried in the wild-type protein. The identified neomorphic surface is thus a candidate for making CMT-associated pathological interactions, and a target for disease correction. Additional result showed that a helix-turn-helix WHEP domain that was appended to GlyRS in metazoans can regulate the neomorphic structural change, and that the gain of function of the CMT mutants might be due to the loss of function of the WHEP domain as a regulator. Overall, the results demonstrate how spatially dispersed and seemingly unrelated mutations can perpetrate the same localized effect on a protein.Keywords
This publication has 31 references indexed in Scilit:
- An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutationsMolecular and Cellular Neuroscience, 2011
- Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathyNature Genetics, 2006
- Global analysis of protein expression in yeastNature, 2003
- Small-angle scattering: a view on the properties, structures and structural changes of biological macromolecules in solutionQuarterly Reviews of Biophysics, 2003
- Glycyl tRNA Synthetase Mutations in Charcot-Marie-Tooth Disease Type 2D and Distal Spinal Muscular Atrophy Type VThe American Journal of Human Genetics, 2003
- Fourier transform ion cyclotron resonance mass spectrometry: A primerMass Spectrometry Reviews, 1998
- Decreased Accumulation or Increased Isoleucyl-tRNA Synthetase Activity Confers Resistance to the Cyclic β-Amino Acid BAY 10-8888 in Candida albicans and Candida tropicalisAntimicrobial Agents and Chemotherapy, 1998
- Familial amyotrophic lateral sclerosis1997
- Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidationProtein Science, 1993
- Genetic and clinical aspects of Charcot‐Marie‐Tooth's diseaseClinical Genetics, 1974